Alliance Technologies - Laboratories

Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.

Pharmaron is a contract research organization (CRO).

Services:
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services

www.pharmaron.com

CRO - Contract Research Organization
Library Synthesis
CADD
Bioorganic Chemistry
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
ChemInformatics
in vitro Biology
in vitro Screening
Structural Biology
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
Biomarkers
in vitro ADME
in vivo PK
PKPD
QA
Regulatory Affairs
Discovery Biologics
Process Chemistry
API Manufacturing
Material Science
Formulation Development
Drug Product Manufacturing
Toxicology
Safety Pharmacology
Genetic Toxicology
DART
Pathology
Immunotoxicity
Bioanalytical
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
QWBA
mARG
Clinical AME
Mass Balance
Metabolite Profiling
Microdosing Phase 0
Absolute Bioavailability
DDI
First-in-Human (FIH)
Thorough QT(TQT)
Ethnobridging

Agere is a global leader in bioavailability enhancement and cGMP services. Our comprehensive formulation design and development capabilities leverage Agere's Quadrant 2 solubilization formulation platform. Quadrant 2 empowers formulation development to efficiently explore a broader design space. Adhering to quality by design (QbD) guidelines de-risks results to achieve your target product profile.

All client services -- from formulation through clinical trials materials manufacturing -- are customized per API and done on a fee-for-service basis.

Formulation Development
• Formulation design and development
• Solubilization formulation expertise
• Innovative analytical technologies
• Materials science and characterization
• Computational modeling

cGMP Manufacturing
• Spray drying
• Tablets
• Capsules
• Inhalation powders
• Topical dosage forms

cGMP Analytical
• Full support for manufacturing and release testing
• Method development and transfer
• Method qualification/validation
• Full stability suite of services

EMAIL: info@agerepharma.com or careers@agerepharma.com

AMCO Proteins is a leading dairy protein manufacturer focused on powder based nutritional and functional solutions for the food, beverage and nutrition markets for over 60 years. With our team of industry experts, we’re positioned to serve customers from the initial stages of product conceptualization, through formulation and finally bulk manufacturing.

Your unique challenges need unique solutions: from custom formulations to prototype production, private label to R&D partnerships, we are here to help.

Our product portfolio includes:
-Hydrolysates
-Protein Blends
-Milk Proteins
-Whey Proteins
-Casein & Caseinates

Our passion for protein drives to us innovate and develop new proteins for various applications. With our team of industry experts, we promise to provide you the highest quality proteins and best customer service to exceed your expectations and help your business grow.

API MANUFACTURING:
Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our focus is providing bulk (Schedule II–V) controlled actives, however non-controlled APIs are also within our project portfolio.

ANALYTICAL SERVICES:
Apertus performs analytical methods development and services on a variety of instrument platforms. Our primary focus is LC (UV), LCMS and GCMS. We can use existing methods or develop novel methods on a per-project basis. In addition, we can provide methods validation, impurity identification and tech transfer packages.

PHARMACEUTICAL SERVICES:
Apertus provides services for drug discovery and preclinical development on a kilo-lab scale. We can supply intermediates, specialty chemical synthesis, process optimization and scale-up services. In addition we can aid in characterizing RLDs via dissolution profiles, chemical analysis and microscopy. All services can be provided under cGMP if desired.

I manage the Drug Product Manufacturing and Discovery Biology for Archer CPS. I serve multiple roles in Archer’s drug discovery, manufacturing and analytical work. My experience ranges from industrial to academic to non-profit environments, working in several fields including Chemistry, Biochemistry, Structural Biology and Drug Formulation. I have developed several immediate and modified release formulations of novel therapeutics and has completed Phase I manufacture of drug product in support of regulatory filings for Archer. I am actively engaged in collaborative efforts with Archer biologists to screen and validate novel drug compounds and targets in addition to overseeing drug formulation, manufacture, and analysis. I have developed many methods for small molecule isolation and characterization for drug discovery, as well as conventional quality control tests required for drug substance and drug product release and stability. I work closely with Archer CPS's Quality Services group in the preparation of the CMC sections for IND and IMPD submissions.